N
Nitin
About Nitin
Data last updated:
Nitin is a Director at Eydia Cure Private Limited (since 2023) and Director at Innovega Pharma Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Eydia Cure Private Limited at ₹11.02 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eydia Cure Private Limited U24290DL2020PTC368740 | Director | 06 May 2023 | 2020 | ₹11.02 Cr (FY 2024) | Active |
 Innovega Pharma Private Limited U47721DL2025PTC449300 | Director | 29 May 2025 | 2025 | Active |
Board colleagues of Nitin
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anant Kumar Pandey | 09295790 | Eydia Cure Private Limited , Innovega Pharma Private Limited | Director |
| Ejazul Hasan | 07854420 | Eydia Cure Private Limited , Innovega Pharma Private Limited | Director |
| Mohd Danish Israr | 09295660 | Eydia Cure Private Limited , Innovega Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nitin
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nitin
Nitin currently holds 2 directorships: Eydia Cure Private Limited (Director, since 06 May 2023, revenue ₹11.02 Cr (FY 2024)); Innovega Pharma Private Limited (Director, since 29 May 2025).
Nitin was first appointed on 06 May 2023 as Director at Eydia Cure Private Limited. The most recent appointment on record is 29 May 2025 at Innovega Pharma Private Limited.
The current boards of Nitin's companies include Anant Kumar Pandey (Eydia Cure Private Limited), Ejazul Hasan (Eydia Cure Private Limited), Mohd Danish Israr (Eydia Cure Private Limited).